Last reviewed · How we verify

Ibuprofen + Paracetamol

Ullevaal University Hospital · FDA-approved active Small molecule

Ibuprofen and paracetamol work synergistically to reduce pain and fever through inhibition of prostaglandin synthesis and central nervous system effects.

Ibuprofen and paracetamol work synergistically to reduce pain and fever through inhibition of prostaglandin synthesis and central nervous system effects. Used for Mild to moderate pain, Fever reduction, Headache.

At a glance

Generic nameIbuprofen + Paracetamol
Also known asIbuprofen, ATC code: M01A E01, Paracetamol (Acetaminophen), ATC code: N02B E01
SponsorUllevaal University Hospital
Drug classFixed-dose combination of NSAID and analgesic/antipyretic
TargetCOX-1/COX-2 (ibuprofen); central nervous system analgesic/antipyretic pathways (paracetamol)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin production and providing analgesic, antipyretic, and anti-inflammatory effects. Paracetamol (acetaminophen) primarily acts as a central analgesic and antipyretic agent, with mechanisms involving serotonergic and endocannabinoid pathways. The combination provides enhanced pain relief and fever reduction through complementary mechanisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: